These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Assessment of Topical Corticosteroid Prescribing, Counseling, and Communication Among Dermatologists and Pharmacists. Millard AN; Stratman EJ JAMA Dermatol; 2019 Jul; 155(7):838-843. PubMed ID: 30916731 [TBL] [Abstract][Full Text] [Related]
3. Not all topical corticosteroids are created equal! Optimizing therapeutic outcomes through better understanding of vehicle formulations, compound selection,and methods of application. Del Rosso JQ; Kircik LH J Drugs Dermatol; 2012 Dec; 11(12):s5-8. PubMed ID: 23547332 [TBL] [Abstract][Full Text] [Related]
4. Factors impacting the combination of topical corticosteroid therapies for psoriasis: perspectives from the International Psoriasis Council. van de Kerkhof PC; Kragballe K; Segaert S; Lebwohl M; J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1130-9. PubMed ID: 21564329 [TBL] [Abstract][Full Text] [Related]
5. The mystical effects of dermatological vehicles. Surber C; Smith EW Dermatology; 2005; 210(2):157-68. PubMed ID: 15724099 [TBL] [Abstract][Full Text] [Related]
6. Long-term topical corticosteroid use and risk of skin cancer: a systematic review. Ratib S; Burden-Teh E; Leonardi-Bee J; Harwood C; Bath-Hextall F JBI Database System Rev Implement Rep; 2018 Jun; 16(6):1387-1397. PubMed ID: 29894408 [TBL] [Abstract][Full Text] [Related]
7. Topical corticosteroids and unwanted local effects. Improving the benefit/risk ratio. Mori M; Pimpinelli N; Giannotti B Drug Saf; 1994 May; 10(5):406-12. PubMed ID: 8037890 [TBL] [Abstract][Full Text] [Related]
8. Clinical and cost-effectiveness of once-daily versus more frequent use of same potency topical corticosteroids for atopic eczema: a systematic review and economic evaluation. Green C; Colquitt JL; Kirby J; Davidson P; Payne E Health Technol Assess; 2004 Nov; 8(47):iii,iv, 1-120. PubMed ID: 15527669 [TBL] [Abstract][Full Text] [Related]
9. The pattern of topical corticosteroid prescribing in the United States, 1989-1991. Stern RS J Am Acad Dermatol; 1996 Aug; 35(2 Pt 1):183-6. PubMed ID: 8708016 [TBL] [Abstract][Full Text] [Related]
10. Topical corticosteroids in infants: prescribing pattern and prescribing errors in Bahrain. Al Khaja KA; Damanhori AH; Al-Ansari TM; Sequeira RP Pharm World Sci; 2007 Aug; 29(4):395-9. PubMed ID: 17295089 [TBL] [Abstract][Full Text] [Related]
11. Systematic review of published trials: long-term safety of topical corticosteroids and topical calcineurin inhibitors in pediatric patients with atopic dermatitis. Siegfried EC; Jaworski JC; Kaiser JD; Hebert AA BMC Pediatr; 2016 Jun; 16():75. PubMed ID: 27267134 [TBL] [Abstract][Full Text] [Related]
13. A Review of Topical Corticosteroid Foams. Payne J; Habet KA; Pona A; Feldman SR J Drugs Dermatol; 2019 Aug; 18(8):756-770. PubMed ID: 31424707 [TBL] [Abstract][Full Text] [Related]
14. The topical corticosteroid classification called into question: towards a new approach. Humbert P; Guichard A Exp Dermatol; 2015 May; 24(5):393-5. PubMed ID: 25707534 [TBL] [Abstract][Full Text] [Related]
15. Contact allergens in topical corticosteroid vehicles: analysis of product composition. Dumycz K; Osinka K; Feleszko W Contact Dermatitis; 2017 Apr; 76(4):254-255. PubMed ID: 28317192 [No Abstract] [Full Text] [Related]